VIA
RAPT

Virtus Investment Advisers’s RAPT Therapeutics RAPT Stock Holding History

Virtus Investment Advisers’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,229
Closed -$245K – 485
2025
Q4 		$245K Buy
+7,229
New +$225K 0.07% 338

Virtus Investment Advisers's RAPT Position: Q1 2026 in Review

Virtus Investment Advisers sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 7,229 shares — an estimated $245K sold.

Virtus Investment Advisers first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $245K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

  • Virtus Investment Advisers reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtus Investment Advisers sold 7,229 RAPT Therapeutics shares in Q1 2026, an estimated $245K.
  • Virtus Investment Advisers first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
  • Virtus Investment Advisers's RAPT Therapeutics position peaked at $245K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.